Testing a new continuous glucose monitor with flash readings
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new sensor system that tracks glucose levels continuously and can give a quick reading when you wave a device over it. It aims to see if it's safe and accurate for people with diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with diabetes for at least 1 year.
- You are willing to follow the study plan and sign a consent form.
- You have not had severe low blood sugar (causing passing out or seizures) in the last 6 months.
- You have not had diabetic ketoacidosis needing emergency care or hospital stay in the last 6 months.
- You do not have a condition that would make wearing the sensor difficult (like severe skin issues or arm deformities).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests the ROME GS System, a glucose monitoring device that measures blood sugar levels. The system includes a sensor placed under the skin and a transmitter worn on the body. If you have diabetes and want to help evaluate a new way to track your blood sugar, this trial may be for you.
This trial studies how well a continuous glucose monitor (a sensor that tracks glucose) works for managing blood sugar in adults with type 1 or type 2 diabetes. You may need to wear sensors and have glucose levels adjusted during clinic visits to test safety and effectiveness.
This study tests a new continuous glucose monitor (CGM) that you wear for 14 days. It checks how accurate the device is and how well it helps track your blood sugar levels, all while being safe and easy to use.
This study tests a new glucose sensor placed inside a blood vessel to see how well it measures blood sugar. If you have diabetes and use intensive insulin therapy, this could be a way to help improve monitoring.
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
This trial tests if using a continuous glucose monitor (a small sensor that checks your sugar levels without fingersticks) helps young adults manage type 2 diabetes better. You will wear the sensor and use a phone app to track your glucose.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.